Indication

Childhood Rhabdomyosarcoma

1 clinical trial

1 product

Clinical trial

NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of Erdafitinib in Patients With Tumors Harboring FGFR1/2/3/4 Alterations

Status: Active (not recruiting), Estimated PCD: 2023-09-30

Product